ProShare Advisors LLC Has $111,000 Stake in Nano-X Imaging Ltd. (NASDAQ:NNOX)

ProShare Advisors LLC increased its position in Nano-X Imaging Ltd. (NASDAQ:NNOX) by 50.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 15,464 shares of the company’s stock after purchasing an additional 5,216 shares during the quarter. ProShare Advisors LLC’s holdings in Nano-X Imaging were worth $111,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of NNOX. US Bancorp DE raised its stake in shares of Nano-X Imaging by 388.7% in the 4th quarter. US Bancorp DE now owns 3,470 shares of the company’s stock valued at $25,000 after buying an additional 2,760 shares in the last quarter. Quadrant Capital Group LLC increased its stake in Nano-X Imaging by 464.9% in the fourth quarter. Quadrant Capital Group LLC now owns 7,016 shares of the company’s stock valued at $51,000 after acquiring an additional 5,774 shares during the period. Quantum Private Wealth LLC acquired a new position in Nano-X Imaging in the fourth quarter worth about $72,000. Signaturefd LLC lifted its stake in Nano-X Imaging by 164.6% during the fourth quarter. Signaturefd LLC now owns 10,391 shares of the company’s stock worth $75,000 after purchasing an additional 6,464 shares during the period. Finally, Bayesian Capital Management LP acquired a new stake in Nano-X Imaging during the fourth quarter valued at approximately $81,000. Institutional investors and hedge funds own 21.49% of the company’s stock.

Nano-X Imaging Trading Up 2.1%

Shares of Nano-X Imaging stock opened at $5.23 on Tuesday. The stock has a market capitalization of $302.18 million, a price-to-earnings ratio of -6.15 and a beta of 2.03. The firm’s 50-day moving average price is $5.02 and its two-hundred day moving average price is $6.29. Nano-X Imaging Ltd. has a 1-year low of $3.75 and a 1-year high of $11.00.

Nano-X Imaging (NASDAQ:NNOX) last released its quarterly earnings results on Thursday, May 22nd. The company reported ($0.21) EPS for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.02. Nano-X Imaging had a negative return on equity of 27.63% and a negative net margin of 465.38%. The business had revenue of $3.00 million for the quarter, compared to analyst estimates of $3.98 million. As a group, equities research analysts predict that Nano-X Imaging Ltd. will post -0.92 EPS for the current year.

Analyst Ratings Changes

Several research firms have recently weighed in on NNOX. Alliance Global Partners reiterated a “buy” rating on shares of Nano-X Imaging in a research note on Thursday, May 22nd. Cantor Fitzgerald dropped their price objective on Nano-X Imaging from $12.00 to $9.00 and set an “overweight” rating for the company in a research note on Tuesday, April 1st. Finally, D. Boral Capital cut their price objective on Nano-X Imaging from $15.00 to $10.00 and set a “buy” rating for the company in a report on Friday, May 23rd.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.